Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

David Metcalfe has been awarded both the prestigious Syme Medal and the AOUK&I Trauma Research Prize 2019 in recognition of his DPhil work in musculoskeletal science.

Horizontal portrait of David Metcalfe

Both awards recognised David's work undertaken as part of his NDORMS DPhil which he completed at the University of Oxford earlier this year. David delivered a number of studies that used routinely collected healthcare data to help clinicians provide better care for older adults with hip fractures. This work found widespread variation and even systematic inequalities in terms of the operations being offered to patients with broken hips. It also showed that the Hip Fracture Best Practice Tariff in England – which pays hospitals a supplement for providing high quality healthcare – improved quality of care and outcomes for these patients.

"These awards are important because they recognise the huge potential of data already collected by the NHS to improve patient care," said David.

The Syme Medal is awarded annually by The Royal College of Surgeons of Edinburgh for doctoral research that is "likely to influence clinical practice". The AOUK&I Trauma Research Prize is open to all surgeons in training for papers focused on any aspect of musculoskeletal trauma. David's DPhil research was funded by an Oxford-UCB Prize Fellowship.

Similar stories

Small mechanical forces in immune cells measured at unprecedented sensitivity

Kennedy Main Research

Oxford researchers have used advanced microscopy techniques to measure previously unseen forces generated by cells during an immune response; a breakthrough for mechanobiology and future advances in health and disease.

NDORMS researchers awarded for Dupuytren research

Awards Hand Kennedy Main

Three NDORMS researchers have received awards from the International Dupuytren Society, a patient organisation that brings together Dupuytren Disease patient societies from across the world.

Hope for rheumatoid arthritis patients who are non-responsive to anti-TNF

Arthritis Kennedy Main

New research published in The Lancet shows that tocilizumab is a more effective treatment than rituximab for rheumatoid arthritis patients with a poor response to anti-tumour necrosis factor (TNF).

A new study maps the expression of innate immune receptors during the course of arthritis

Arthritis Kennedy Main

The research, which was a collaboration with researchers from Oxford University and Queen Mary University of London and published in Journal of Autoimmunity, looked at changes in receptors known as toll-like receptors (TLRs) in arthritis at different stages of disease.

International Women's Day

Department Main

It’s International Women's Day! This year’s theme is #Choosetochallenge. We’re celebrating some of the amazing women at NDORMS, and asking them what changes they’d like to see in medical sciences over the next 100 years.

Patients and carers invited to join new group helping to shape research and treatment of bones, muscles and joints

Main PPI

Oxford’s newest patient partner group, OPEN ARMS launches today to explore the causes, treatment and care for patients with musculoskeletal conditions. Its first three patient partners explain why they are involved and invite other members of the public to join the team.